Mattias Drosten

15PUBLICATIONS
52CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 01, 2026
A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance.

|Dec 02, 2025
A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance.

Vasiliki Liaki, Sara Barrambana, Myrto Kostopoulou

|Nov 11, 2025
The repressor Capicua is a barrier to lung tumor development driven by Kras/Trp53 mutations.

Irene Ballesteros-González, Iván Hernández-Navas, Oksana Brehey

|Oct 29, 2025
The rapidly growing landscape of RAS inhibitors: from selective allele blockade to broad inhibition strategies.

Matthias Drosten, Mariano Barbacid

|Mar 31, 2025
Active R-RAS2/TC21 prevents cell cycle arrest and morphological alterations in mouse embryonic fibroblasts lacking RAS proteins.

Isabel Fernández-Pisonero, L Francisco Lorenzo-Martín, Mattias Drosten

|Oct 10, 2023
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer.

Irati Macaya, Marta Roman, Connor Welch

Pageof 3

Frequent Collaborators

10 joint publications

Mariano Barbacid

3 joint publications

Lucía Simón-Carrasco

3 joint publications

Gerardo Jiménez

3 joint publications

Monica Musteanu